Blood-clump assisted procedure effective in repairing macular hole

Article

A novel blood clump-assisted procedure safely and efficiently labels the posterior vitreous and coats the internal limiting membrane (ILM) for the reparation of macular hole (MH).

A novel blood clump-assisted procedure safely and efficiently labels the posterior vitreous and coats the internal limiting membrane (ILM) for the reparation of macular hole (MH), states an investigation featured in Retina.

A team led by Dr Lai Chi-Chun, Department of Ophthalmology, Chang-Gung Memorial Hospital, Taoyuan, Taiwan, enrolled 26 patients with MH. Each patient underwent ILM peeling and was administered a blood clump consisting of autologlous whole blood with 5% glucose water.

The solution was used to cover the ILM surface in the macular area. Forceps were used to extract the blood clump-coated ILM. The outcome measures included MH closure rate, preoperative and postoperative best-corrected visual acuity change and retinal changes.

In 24 eyes the MHs were closed by single surgery and 2 holes were closed after a second gas-fluid exchange. Preoperative and postoperative mean best-corrected visual acuities were 0.96 ± 0.3 and 0.38 ± 0.3, respectively.

Using the novel blood clump-assisted procedure enhanced the visibility of ILM and was proved to be safe and effective in repairing MH.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.